Tramadol (Avenue Therapeutics)

N/A

Report date: 2023/11/24 20:10:21

NME

Base Information

Drug NameTramadol (Avenue Therapeutics)

Drug Alias NameIV tramadol (Revogenex/Avenue Therapeutics)Tramadol hydrochloride (Revogenex/Avenue Therapeutics)Tramadol intravenous (Revogenex/Avenue Therapeutics)AVE-901RVX 109

ClassificationSmall molecules

Mechanisms of ActionMu opioid receptor agonists

TargetsMu opioid receptor

Therapy Area/IndicationsPain, Postoperative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesRevogenex Inc

China Registration ClassN/A

Develop Information

Active CompaniesAvenue Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsPain, Postoperative

Inactive IndicationsN/A

Other Information

ATC CodeN/A